A sweet dividend stock I’d buy for income and potential growth
The Motley Fool
Published Nov 13, 2018 08:59
Updated Nov 13, 2018 09:15
During 2018, Tate & Lyle (LON:TATE) (LSE: TATE) has been celebrating the company’s 140th birthday at the Thames Refinery in Silvertown. When Henry Tate, a shopkeeper from Liverpool, opened the first sugar refinery in 1878, the same year the light bulb was invented and Cleopatra’s Needle was raised onto its base in London, he probably could not have foreseen how the company and the industry would develop over the years.
On November 8, the company’s half-year results showed a small profit increase and the management maintained its future outlook. Yet analysts pointed out the lack of real growth in the otherwise strong fundamental story. So what should we expect from Tate & Lyle?
When will Tate & Lyle start to grow again? Although shoppers tend to visualise the Tate & Lyle brand with packs of sugar in supermarket aisles, the company’s primary focus is on producing sweeteners and other bulk ingredients for food manufacturers. Tate & Lyle are the exclusive UK producers of the Splenda artificial sweetener.
Within the past few years, investors have been quite concerned about the prospects of TATE shares over profit warnings and a managerial approach that has not given a clear indication as to how the company would grow.
Then, with CEO Nick Hampton at the helm, came a range of recent cost-cutting measures and productivity increases – providing a positive momentum to the share price. Sales in the Americas, as well as the Far East, have also been going up and the rising price of commodities has given a boost to profits. As a result, TATE shares have bounced off their March lows and are now holding above 700p.
Tate & Lyle are likely to be one of the companies to benefit from consumers’ changing habits as shoppers move away from sugar and towards healthier food and drink options, especially in the US – the company’s largest market. Moreover, the sugar tax that came into effect in the UK in April 2018 is likely to help TATE increase revenues, as Splenda is replacing aspartame and saccharine in low-calorie drinks.
TATE’s healthy balance sheet also gives the company various options to make acquisitions in niche health food markets – a move that would help grow its portfolio. In other words, before too long, TATE bulls will probably be proven right to believe in the management’s commitment to create shareholder value and to grow the company both organically and through acquisitions.
Get The App
Reinvesting the sweet dividend yield of TATE shares Despite the lack of current growth at TATE, its dividends make the shares attractive. TATE’s dividend yield is over 4% – another reason why I believe Tate & Lyle shares belong to a capital-growth portfolio. The next dividend payment is scheduled for early January 2019 to shareholders of record on Thursday, November 22nd.
The bottom line on TATE shares TATE shares have been flat over the past 12 months. During 2019, I expect the shares to trade between 650-750p. Within 4-5 years both value and dividend growth investors are likely to be rewarded handsomely. By then the company could even become a bid target by other food manufacturers.
Tezcan has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.